Sign Out
Instructions for Use/Handling: Parenteral drug products should be inspected visually for particulate matter, and discoloration prior to administration.
Praxbind must not be mixed with other medicinal products. A pre-existing intravenous line may be used for administration of Praxbind. The line must be flushed with sterile sodium chloride 9 mg/ml (0.9 %) solution prior to and at the end of infusion. No other infusion should be administered in parallel via the same intravenous access.
Prior to use, the unopened vial may be kept at room temperature (up to 30°C) for up to 48 hours, if stored in the original package in order to protect from light. Once solution has been removed from the vial, chemical and physical in-use stability of idarucizumab has been demonstrated for 6 hours at room temperature. The solution should not be exposed to light for more than 6 hours.
Praxbind is for single-use only and does not contain preservatives.
No incompatibilities between Praxbind and polyvinyl chloride, polyethylene or polyurethane infusion sets or polypropylene syringes have been observed.
